$31.3M Trump-Linked Bet Powers XWell AI Airport Screening

A Trump family-linked investment group is placing a major wager on the future of public health screening at airports. American Ventures, an entity with ties to the former president's family, is investing $31.3 million in XWell Inc. (XWEL) to accelerate the deployment of its artificial intelligence-powered infectious disease screening systems across U.S. travel hubs, according to a report. The funding will specifically support the rollout of XWell's ConMRx platform, which uses thermal imaging and AI algorithms to detect elevated body temperatures and potential signs of illness in real-time. This technology is designed for seamless integration into existing airport security and checkpoint infrastructures. "This investment allows us to scale our solution at a critical time for national and global health security," said a company spokesperson. The deal underscores growing private sector interest in health-tech solutions for mass transit venues, particularly those with political connections that can facilitate government and public-sector contracts. XWell, which focuses on non-invasive health screening, has been actively pursuing partnerships with airports and government agencies since the onset of the COVID-19 pandemic. The backing from American Ventures provides a significant capital infusion and potentially influential advocacy as XWell seeks to formalize its systems within major U.S. airports.